Tracking hospital infections and germs from nose and rectum swabs
Part of Infections clinical trials.
This trial monitors healthcare-associated infections and antibiotic resistance by collecting swabs from the nose and rectum while you are hospitalized. It may help doctors better understand how often these infections happen and how to prevent them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently admitted as a hospital inpatient to a participating ward
- You can safely have a swab taken from inside your nose (nares)
- You can safely have a swab taken from your rectum
- You do not have a known bleeding disorder
- Your platelet count is not below 50,000
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a rapid molecular test can help doctors choose the right antibiotics faster for hospitalized patients. It aims to improve how antibiotics are used and reduce unnecessary side effects.
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
This study looks at the community of microbes in the body (your “microbiome”) using samples like stool, urine, and possibly tissue. It may help researchers understand how these microbes relate to health in hospital patients.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
This study monitors patients with worsening cirrhosis for certain hard-to-treat bacteria in the gut. It aims to understand how these bacteria spread and how to prevent infections.
This study looks at whether patients in the hospital who carry certain resistant bacteria in their gut are more likely to get infections. The goal is to understand the risk so doctors can better protect you.
Hear when a new Antimicrobial Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.